Stocks and Investing Stocks and Investing
Fri, September 17, 2021
Thu, September 16, 2021
Wed, September 15, 2021
Tue, September 14, 2021
Mon, September 13, 2021
Fri, September 10, 2021

Geoff Meacham Upgraded (BBIO) to Strong Buy and Held Target at $75 on, Sep 10th, 2021


Published on 2024-10-27 17:52:48 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of B of A Securities, Upgraded "BridgeBio Pharma, Inc." (BBIO) to Strong Buy and Held Target at $75 on, Sep 10th, 2021.

Geoff has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Geoff's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Geoff


  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $66 on, Friday, August 6th, 2021
  • Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $80 on, Friday, May 21st, 2021